PUSCH, MICHAEL
 Distribuzione geografica
Continente #
AS - Asia 5.973
NA - Nord America 2.209
SA - Sud America 1.035
EU - Europa 939
AF - Africa 236
Continente sconosciuto - Info sul continente non disponibili 82
OC - Oceania 4
Totale 10.478
Nazione #
SG - Singapore 3.409
US - Stati Uniti d'America 1.979
BR - Brasile 699
CN - Cina 610
HK - Hong Kong 377
VN - Vietnam 282
IT - Italia 188
DE - Germania 176
TR - Turchia 175
FR - Francia 131
IN - India 123
RU - Federazione Russa 106
UZ - Uzbekistan 106
IQ - Iraq 102
KR - Corea 100
PH - Filippine 90
ID - Indonesia 81
BD - Bangladesh 76
JP - Giappone 71
MY - Malesia 71
MX - Messico 70
VE - Venezuela 69
AR - Argentina 64
MA - Marocco 60
UA - Ucraina 60
SA - Arabia Saudita 55
FI - Finlandia 52
CA - Canada 49
ZA - Sudafrica 49
EC - Ecuador 48
CO - Colombia 46
GB - Regno Unito 43
IR - Iran 41
UY - Uruguay 40
KE - Kenya 39
NL - Olanda 39
PY - Paraguay 39
JM - Giamaica 35
AZ - Azerbaigian 27
JO - Giordania 27
DZ - Algeria 24
AL - Albania 23
CR - Costa Rica 23
KZ - Kazakistan 20
MM - Myanmar 18
PA - Panama 18
TN - Tunisia 18
BO - Bolivia 16
ES - Italia 16
NP - Nepal 16
PK - Pakistan 16
BH - Bahrain 14
HN - Honduras 14
PL - Polonia 14
EG - Egitto 13
GE - Georgia 12
KG - Kirghizistan 12
LT - Lituania 10
AT - Austria 9
IL - Israele 9
CI - Costa d'Avorio 8
IE - Irlanda 8
SE - Svezia 8
SN - Senegal 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
PE - Perù 7
AM - Armenia 6
BE - Belgio 5
BG - Bulgaria 5
BY - Bielorussia 5
GR - Grecia 5
RS - Serbia 5
XK - ???statistics.table.value.countryCode.XK??? 5
CZ - Repubblica Ceca 4
GT - Guatemala 4
HR - Croazia 4
MD - Moldavia 4
NI - Nicaragua 4
OM - Oman 4
DO - Repubblica Dominicana 3
EE - Estonia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AU - Australia 2
BB - Barbados 2
CY - Cipro 2
DK - Danimarca 2
FJ - Figi 2
HU - Ungheria 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MU - Mauritius 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
SV - El Salvador 2
Totale 10.376
Città #
Singapore 2.848
Santa Clara 418
Hong Kong 367
San Jose 269
Hefei 230
Ashburn 204
Dallas 152
Beijing 125
Frankfurt am Main 123
Ho Chi Minh City 107
Lauterbourg 105
Tashkent 98
Seoul 95
Hanoi 61
Tokyo 59
Los Angeles 57
São Paulo 52
Istanbul 49
New York 39
Nairobi 35
Montevideo 33
Kuala Lumpur 31
Erbil 30
Amman 26
Helsinki 26
Jeddah 26
Baku 25
Rio de Janeiro 24
Kingston 23
Baghdad 22
Munich 22
Casablanca 21
Johannesburg 21
Buffalo 20
Asunción 19
North Bergen 19
San José 18
Guayaquil 17
Orem 17
Panama City 17
Cape Town 15
Jakarta 15
Lappeenranta 15
Moscow 15
Tirana 15
Caracas 14
Brasília 13
Brooklyn 13
Milan 13
Montreal 13
Belo Horizonte 12
Council Bluffs 12
Nuremberg 12
Riyadh 12
Ankara 11
Bengaluru 11
El Progreso 11
Haiphong 11
Houston 11
Izmir 11
London 11
Maracaibo 11
Bishkek 10
Bogotá 10
Ciudad del Este 10
Curitiba 10
Da Nang 10
Dhaka 10
Hyderabad 10
Naples 10
Quito 10
Warsaw 10
Amsterdam 9
Cavallino 9
Minamishinagawa 9
Mumbai 9
Petaling Jaya 9
Philadelphia 9
Phoenix 9
Porto Alegre 9
Quezon City 9
Thái Nguyên 9
Toronto 9
Turku 9
Abidjan 8
Baltimore 8
Bandung 8
Chicago 8
Davao City 8
Delhi 8
Falkenstein 8
Genoa 8
Manama 8
Manila 8
Medellín 8
New Delhi 8
Palermo 8
Rome 8
Surabaya 8
Tunis 8
Totale 6.563
Nome #
Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition 4.712
Biophysical Aspects of Neurodegenerative and Neurodevelopmental Disorders Involving Endo-/Lysosomal CLC Cl-/H+ Antiporters 107
Distinct ClC‐6 and ClC‐7 Cl− sensitivities provide insight into ClC‐7's role in lysosomal Cl− homeostasis 102
TMEM9B Regulates Endosomal ClC-3 and ClC-4 Transporters 85
Take a big sip and shrink it with ASOR 82
Molecular determinants underlying volume-regulated anion channel subunit-dependent oxidation sensitivity 72
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels. 70
Mechanisms of activation of LRRC8 volume regulated anion channels 69
ClC-5: Physiological role and biophysical mechanisms 68
BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers 68
The VRAC blocker DCPIB directly gates the BK channels and increases intracellular Ca2+ in melanoma and pancreatic duct adenocarcinoma cell lines 67
Functional and Structural Characterization of ClC-1 and Nav1.4 Channels Resulting from CLCN1 and SCN4A Mutations Identified Alone and Coexisting in Myotonic Patients 66
Voltage-Gated Sodium Channel Dysfunctions in Neurological Disorders 64
Cisplatin activates volume sensitive LRRC8 channel mediated currents in Xenopus oocytes 64
Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis 63
Pharmacologic activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels. 62
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy) propionic acid 62
Activation of Two Distinct Potassium Currents in Melanoma Cells by Oxidation 62
Chloride/proton antiport of mammalian CLC proteins 60
Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model 59
The biophysics of piezo1 and piezo2 mechanosensitive channels 59
Large transient capacitive currents in wild-type lysosomal Cl-/H+ antiporter ClC-7 and residual transport activity in the proton glutamate mutant E312A 58
A single point mutation reveals gating of the human ClC-5 Cl-/H+ antiporter 58
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 58
Kidney CLC-Kchloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms 57
Altered voltage-dependence of slowly activating chloride-proton antiport by late endosomal ClC-6 explains distinct neurological disorders 57
Interactomic exploration of LRRC8A in volume-regulated anion channels 57
Regulatory-auxiliary subunits of CLC chloride channel-transport proteins 56
Gain of function of sporadic/familial hemiplegic migraine-causing SCN1A mutations: Use of an optimized cDNA 55
The human two-pore channel 1 is modulated by cytosolic and luminal calcium 55
ALLIN: A tool for annotation of a protein alignment combined with structural visualization 55
Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high affinity ligands. 54
Gating competence of constitutively open ClC-0 mutants revealed by the interaction with a small organic inhibitor. 54
Extracellular Determinants of Anion Discrimination of the Cl-/H+ Antiporter Protein CLC-5 54
Ion Channel Involvement in Tumor Drug Resistance 54
Role of PKC in the Regulation of the Human Kidney Chloride Channel ClC-Ka 54
Dynamics of Interneurons in the Presence of a Sodium Channel Mutation 53
Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene 53
The Arabidopsis central vacuole as an expression system for intracellular transporters: functional characterization of the Cl-/H+ exchanger CLC-7 53
Melatonin protects Kir2.1 function in an oxidative stress‐related model of aging neuroglia 53
IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration 53
Pharmacology and biophysics of CLC channels and transporters 52
Small Molecules Targeting Kidney ClC-K Chloride Channels: Applications in Rare Tubulopathies and Common Cardiovascular Diseases 52
Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes 51
On the mechanism of gating charge movement of ClC-5, a human Cl(-)/H(+) antiporter 51
Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin 51
NS-11021 Modulates Cancer-Associated Processes Independently of BK Channels in Melanoma and Pancreatic Duct Adenocarcinoma Cell Lines 51
An optical assay of the transport activity of ClC-7 51
I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes 50
Is Neuronal Fatigue the Cause of Migraine? 50
GlialCAM, a Protein Defective in a Leukodystrophy, Serves as a CIC-2 Cl- Channel Auxiliary Subunit 48
Molecular switch for CLC-K Cl- channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 48
Thermal Sensitivity of CLC andTMEM16 Chloride Channelsand Transporters. 48
Identification and Functional Characterization of CLCN1 Mutations Found in Nondystrophic Myotonia Patients 48
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium. 47
The muscle chloride channel ClC-1 is not directly regulated by intracellular ATP. 47
Subunit-dependent oxidative stress sensitivity of LRRC8 volume-regulated anion channels 47
Trpm2 oxidation activates two distinct potassium channels in melanoma cells through intracellular calcium increase 47
TMEM16 Ca Activated Cl Channels and CLC Chloride Channels and Transporters 47
GlialCAM, a CLC-2 Cl- Channel Subunit, Activates the Slow Gate of CLC Chloride Channels 46
Channel or transporter? The CLC saga continues 45
Myotonia-related mutations in the distal C-terminus of ClC-1 and ClC-0 chloride channels affect the structure of a poly-proline helix. 45
Mechanism of Interaction of Niflumic Acid with Heterologously Expressed Kidney CLC-K Chloride Channels. 45
Activation and inactivation of homomeric KvLQT1 potassium channels 45
ClC-5, a human nucleotide regulated Cl- / H+ exchanger 44
A Kick-Start for CLC Antiporters' Pharmacology 44
A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels 43
An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies 42
CLC transport proteins in plants 42
Intracellular proton regulation of ClC-0. 42
Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders 42
Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. 42
Activation and inhibition of kidney CLC-K chloride channels by fenamates 41
CLC Channels and Transporters 41
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. 40
Targeting kidney CLC-K channels: Pharmacological profile in a human cell line versus Xenopus oocytes 40
The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. 39
Determinants of anion-proton coupling in mammalian endosomal CLC proteins. 39
Conversion of the 2 Cl(-)/1 H(+) antiporter ClC-5 in a NO(3)(-)/H(+) antiporter by a single point mutation. 39
Myotonia caused by mutations in the muscle chloride channel gene CLCN1 39
Proton sensing of CLC-0 mutant E166D. 38
CLC chloride channels and transporters: Structure, function, physiology, and disease 38
Buffered diffusion around a spherical proton pumping cell: a theoretical analysis. 37
Structural determinants of interaction, trafficking and function in the ClC-2/MLC1 subunit GlialCAM involved in leukodystrophy 37
Analysis of electrophysiological data. 37
Intracellular CLC Transporters - From Kidney Stones to Intellectual Disability 36
Can unlikely neanderthal chloride channel clc-2 gene variants provide insights in modern human infertility? 36
Relaxing messages from the sarcolemma 35
Chloride transporting CLC proteins. 35
Molecular Mechanisms Underlying Oxidation Sensitivity of VRAC 34
Expression of LRRC8/VRAC currents in Xenopus oocytes: Advantages and caveats 34
Molecular modeling of p-chlorophenoxyacetic acid binding to the ClC-0 channel. 34
Intracellular regulation of human ClC-5 by adenine nucleotides. 33
Alkaline pH block of CLC-K kidney chloride channels mediated by a pore lysine residue 33
Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters 33
Structure of the human ClC-1 chloride channel 33
Biophysical properties of acid-sensing ion channels (ASICs) 33
Molecular pharmacology of kidney and inner ear CLC-K chloride channels 32
The role of protons in fast and slow gating of the Torpedo chloride channel ClC-0. 32
Functional Analyses of Mutations in HEPACAM Causing Megalencephalic Leukoencephalopathy 31
Totale 9.686
Categoria #
all - tutte 27.096
article - articoli 24.189
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 554
Totale 51.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 0 0 3 0 5 0
2024/20253.633 5 7 136 76 364 83 15 180 134 635 1.042 956
2025/20266.148 869 1.122 1.231 945 613 139 523 131 130 186 119 140
2026/2027689 203 135 351 0 0 0 0 0 0 0 0 0
Totale 10.478